OMALIZUMAB

Omalizumab 150 mg/mL injection, 1 mL pen device

OMALIZUMAB (14937E)

Omalizumab 150 mg/mL injection, 1 mL pen device
14937E
Body System:
Manner of administration:Injection
Public
S100 HSD Public
Authority Required

Restriction

Indication: Severe chronic spontaneous urticaria
Treatment phase: Continuing treatment
Quantities & Cost
Max qty packs Max qty units # of repeats DPMQ Max safety net General Patient Charge
Max qty packs: 2 Max qty units: 2 # of repeats: 5 DPMQ: $411.96 Max safety net: $25.00 General Patient Charge: $25.00
Available brands
Omlyclo
Xolair